VIDA: Virtual Diabetes Group Visits Across Health Systems
VIDA:跨卫生系统的虚拟糖尿病小组访问
基本信息
- 批准号:10494186
- 负责人:
- 金额:$ 62.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-24 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY
Of the 30 million adults with DM in the United States, 97% have at least one comorbid condition (e.g.
hypertension, heart disease, kidney disease). DM and DM-related complications disproportionately affect people
of color. The prevalence of DM is higher among Hispanics (12.5%) and African-Americans (11.7%) compared to
non-Hispanic whites (7.5%); Hispanics and African-Americans have higher rates of diabetes-related
complications, including amputations and CKD. Group visits (GVs) can provide patients with comprehensive
care for their multimorbid chronic condition. Diabetes GVs—shared appointments where patients receive self-
management education in a group setting and an individual medical visit—can improve glycemic control,
decrease healthcare utilization, and provide social support and co-learning among peers. While virtual
appointments have become a routine part of clinical care during the COVID-19 pandemic, group visits via virtual
platforms remain uncommon and understudied. Before the model can be widely adopted, important questions
about the effectiveness and implementation of the virtual diabetes GV model need to be addressed. We propose
to build on an established program of in-person diabetes GVs and a virtual diabetes GV pilot by the University
of Chicago and MidWest Clinician’s Network. We aim to implement the virtual GV model (VIDA: Virtual Diabetes
Group Visits Across Health Systems) in two distinct health systems in the Chicago region: ACCESS and
Advocate Aurora Health (AAH). ACCESS is one of the largest federally qualified health centers (FQHCs) in the
U.S. with 35 sites across the Chicago metropolitan area, providing care for 175,000 medically underserved and
low-income patients each year, including over 25,000 patients with diabetes. Advocate Aurora Health (AAH) is
a large, diverse, integrated private not-for profit health system with more than 129 primary care clinics in Illinois
serving over 117,000 patients with diabetes. The ability to train, implement and evaluate virtual group visits
across two distinct health systems provides a unique opportunity to learn about adaptation and the barriers and
facilitators for program implementation. This study will use a type I hybrid effectiveness-implementation design
via a pragmatic cluster randomized trial to assess changes in clinical outcomes among adults with T2DM in
virtual diabetes GVs versus usual care. We will first adapt and implement VIDA at one ACCESS FQHC center
and one AAH primary care clinic using the Form and Function domains of the Complex Health Intervention
Framework. We will assess integration of VIDA into clinical workflow and determine the type of and amount of
training and technical support needed to assist staff in integrating virtual diabetes GV into the clinical setting. We
will then conduct a pragmatic cluster randomized trial of virtual GVs across 9 intervention sites (180 adult patients
with T2DM with A1C >9%) and 9 control sites (360 matched patients) and assess change in A1C from baseline
to 12-months and change in other clinical outcomes including systolic blood pressure and body mass index. We
will assess adoption, implementation, and maintenance of virtual GVs across systems using RE-AIM framework.
项目摘要
在美国有3000万DM的成年人中,有97%的人至少有一个合并症(例如
高血压,心脏病,肾脏疾病)。 DM和与DM相关的并发症对人们的影响不成比例
颜色。与西班牙裔(12.5%)和非裔美国人(11.7%)相比,DM的患病率更高
非西班牙裔白人(7.5%);西班牙裔和非裔美国人的糖尿病率较高
并发症,包括截肢和CKD。小组访问(GVS)可以为患者提供全面的
照顾他们的多病慢性病。糖尿病GVS - 签约,患者接受自我
在小组环境和个人医疗访问中进行管理教育 - 可以改善血糖控制,
减少医疗保健利用,并在同龄人之间提供社会支持和共学习。虽然虚拟
约会已成为共同19日大流行期间临床护理的常规一部分,通过Virtual
平台仍然很常见和理解。在广泛采用模型之前,重要的问题
关于虚拟糖尿病模型的有效性和实施,需要解决。我们建议
建立在大学现场糖尿病GV和大学的虚拟糖尿病飞行员的基础上
芝加哥和中西部临床医生的网络。我们旨在实施虚拟GV模型(VIDA:虚拟糖尿病
芝加哥地区两个不同卫生系统的跨卫生系统的小组访问:访问和
倡导Aurora Health(AAH)。访问是最大的联邦合格卫生中心(FQHC)之一
美国在整个芝加哥都会区拥有35个地点,为175,000个医疗服务不足的护理提供了护理
每年低收入患者,包括超过25,000名糖尿病患者。倡导Aurora Health(AAH)是
伊利诺伊州的大型,潜水员,综合的私人非营利性健康系统,拥有超过129个初级保健诊所
为超过117,000名糖尿病患者提供服务。训练,实施和评估虚拟小组访问的能力
在两个不同的卫生系统中,提供了一个独特的机会,可以了解适应和障碍和
计划实施的促进者。这项研究将使用I型混合有效性 - 实现设计
通过务实的聚类随机试验来评估T2DM成年人的临床结果的变化
虚拟糖尿病GVS与通常的护理。我们将首先在一个访问FQHC中心适应并实施VIDA
以及一个使用复杂健康干预的形式和功能域的AAH初级保健诊所
框架。我们将评估VIDA整合到临床工作流程中,并确定
需要培训和技术支持,以帮助员工将虚拟糖尿病GV整合到临床环境中。我们
然后将在9个干预地点(180名成年患者)进行虚拟GV的务实簇随机试验
具有T2DM,A1C> 9%)和9个对照位点(360名匹配的患者),并评估A1C的变化。
到12个月,以及其他临床结果的变化,包括收缩压和体重指数。我们
将使用RE-AIM框架来评估在系统跨系统中虚拟GV的采用,实施和维护。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Arshiya Ahmed Baig其他文献
Arshiya Ahmed Baig的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Arshiya Ahmed Baig', 18)}}的其他基金
DULCE (Diabetes InqUiry Through a Learning Collaborative Experience)
DULCE(通过学习协作体验进行糖尿病查询)
- 批准号:
10558119 - 财政年份:2023
- 资助金额:
$ 62.27万 - 项目类别:
ARISE (Achieving Routine Intervention and Screening for Emotional health)
ARISE(实现情绪健康的常规干预和筛查)
- 批准号:
10655877 - 财政年份:2023
- 资助金额:
$ 62.27万 - 项目类别:
VIDA: Virtual Diabetes Group Visits Across Health Systems
VIDA:跨卫生系统的虚拟糖尿病小组访问
- 批准号:
10437373 - 财政年份:2021
- 资助金额:
$ 62.27万 - 项目类别:
VIDA: Virtual Diabetes Group Visits Across Health Systems
VIDA:跨卫生系统的虚拟糖尿病小组访问
- 批准号:
10654829 - 财政年份:2021
- 资助金额:
$ 62.27万 - 项目类别:
相似国自然基金
从Cyr61/ITGB4/ATG7介导的自噬途径研究生肌化瘀膏改善糖尿病溃疡慢性炎症分子机制
- 批准号:82374444
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
负载芍药苷智能响应水凝胶的构建及其促进糖尿病型慢性难愈合创面的再生修复
- 批准号:82304728
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于力学仿生的自收缩向心取向纤维敷料的构建及其对糖尿病慢性伤口的修复研究
- 批准号:12302413
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
微环境响应型复合水凝胶敷料程序化治疗糖尿病慢性伤口的研究
- 批准号:52303209
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
铜-黄酮缓释系统的设计及其促进糖尿病慢性伤口愈合的机制研究
- 批准号:82272153
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
相似海外基金
Hypusine as a nutrient-sensing modulator of eIF5A function in β cells
Hypusine 作为 β 细胞中 eIF5A 功能的营养感应调节剂
- 批准号:
10679499 - 财政年份:2023
- 资助金额:
$ 62.27万 - 项目类别:
Multi-Omics at the Intersections of Environment, Diabetes, and Kidney Disease: A Multi-Omics for Health and Disease Study Site
环境、糖尿病和肾脏疾病交叉点的多组学:健康和疾病研究网站的多组学
- 批准号:
10744464 - 财政年份:2023
- 资助金额:
$ 62.27万 - 项目类别:
CommunityRx – Chronic Kidney Disease (CRx-CKD)” An EMR-integrated community resources referral intervention to address structural racism and kidney health disparities in rural North Carolina
CommunityRx — 慢性肾脏病 (CRx-CKD) — 一项与 EMR 整合的社区资源转诊干预措施,旨在解决北卡罗来纳州农村地区的结构性种族主义和肾脏健康差异
- 批准号:
10743421 - 财政年份:2023
- 资助金额:
$ 62.27万 - 项目类别:
Implementation of Communication Disability Collection and Accommodations in Primary Care Settings
在初级保健机构中实施沟通障碍收集和住宿
- 批准号:
10705832 - 财政年份:2022
- 资助金额:
$ 62.27万 - 项目类别:
Supporting Transitions to Primary care among Under-resourced, Postpartum women: The STEP-UP
支持资源不足的产后妇女向初级保健过渡:STEP-UP
- 批准号:
10637553 - 财政年份:2022
- 资助金额:
$ 62.27万 - 项目类别: